What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment

Benzathine penicillin G is the recommended first-line treatment for syphilis, with dosing dependent on the stage of infection: 2.4 million units IM as a single dose for primary, secondary, and early latent syphilis, and 7.2 million units total (administered as 3 doses of 2.4 million units IM at 1-week intervals) for late latent syphilis or latent syphilis of unknown duration. 1

Treatment Recommendations by Stage

Early Syphilis (Primary, Secondary, Early Latent)

  • First-line: Benzathine penicillin G 2.4 million units IM as a single dose 1
  • Alternative regimens (for non-pregnant, penicillin-allergic patients without neurosyphilis):
    • Doxycycline 100 mg orally twice daily for 14 days 1
    • Tetracycline 500 mg orally four times daily for 14 days 1
    • Ceftriaxone 1 g IV/IM daily for 10 days 1

Late Latent Syphilis or Latent Syphilis of Unknown Duration

  • First-line: Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM at 1-week intervals 1
  • Alternative regimens (for non-pregnant, penicillin-allergic patients without neurosyphilis):
    • Doxycycline 100 mg orally twice daily for 28 days 1
    • Tetracycline 500 mg orally four times daily for 28 days 1

Neurosyphilis

  • First-line: Penicillin G aqueous 18-24 million units IV daily, administered as 3-4 million units every 4 hours for 10-14 days 1

Special Populations

Pregnant Women

  • Only recommended treatment: Penicillin G (appropriate for stage) 1
  • If penicillin allergic: Desensitization is required, as no alternative treatments are proven effective during pregnancy 1

HIV-Infected Patients

  • Same regimens as HIV-negative patients, but with closer follow-up 1

Treatment Monitoring and Follow-up

  • Quantitative nontreponemal serologic tests (RPR or VDRL) should be repeated at 6,12, and 24 months 1
  • Treatment success is indicated by a fourfold decline in titers within:
    • 12 months for primary and secondary syphilis
    • 24 months for late latent syphilis 1
  • Approximately 15% of patients may not meet standard criteria for serological cure 12 months after adequate treatment 1

Partner Management

  • All sexual partners should be evaluated clinically and serologically for syphilis 1
  • Partners exposed within 90 days of diagnosis should be treated presumptively even if seronegative 1
  • Partners exposed >90 days before diagnosis should be treated based on clinical and serological evaluation 1

Important Considerations and Precautions

  • When administering penicillin G, monitor for potential allergic reactions, especially in patients with histories of significant allergies or asthma 2, 3
  • For high-dose IV penicillin G (above 10 million units), administer slowly due to potential electrolyte imbalance from potassium content 3
  • If a patient misses a dose in the weekly therapy schedule for late latent syphilis, an interval of 10-14 days between doses might be acceptable before restarting the sequence, but for pregnant women, the full course must be repeated if any dose is missed 1
  • Treatment failure is indicated by persistent or recurrent signs/symptoms, a sustained fourfold increase in non-treponemal tests, or failure to observe the expected fourfold decrease in titers 1

While some studies have explored alternative treatments like azithromycin 4, 5, the CDC continues to recommend penicillin as the first-line treatment for all stages of syphilis due to its proven efficacy and the increasing concerns about antimicrobial resistance with other agents.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.